Table 1.

Published clinical trials with Protamine-mRNA.

Condition	Protamine Formulation	Number	Reference
Metastatic Melanoma	Protamine ICM	NCT00204607	[42]
Prostate Cancer	RNactive CV9103	EudraCT 2008-003967-37	[43]
Prostate Cancer	RNactive CV9104	NCT01817738	[44]
Rabies	RNactive CV7201	NCT02241135	[45]
Non-small Cell Lung Cancer	RNactive CV9201	NCT00923312	[46]
Non-small Cell Lung Cancer	RNactive CV9202	NCT01915524	[47]